Koutaro Yokote - Concepedia

Author

Koutaro Yokote

Also Known As

K Yokote, K. YOKOTE, K. Yokote, K., Yokote, KOUTARO YOKOTE, Kotaro Yokote, Koutaro YOKOTE, Koutaro Yokote, Koutaro Yokote (645076), Lessel, Davor

639

Publications

21.2K

Citations

H-Index

235

Concepts

All Affiliations

Chiba University Chiba University Hospital The University of Osaka International University of Health and Welfare The University of Tokyo

About

Koutaro Yokote is an author at Chiba University specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	78	5.2K
2	Public Health	17	21	2.1K
3	Health Sciences	13	17	552
4	Natural Sciences	7	7	1.3K
5	Biochemistry	4	4	736

Koutaro Yokote

228

Publications

18.4K

Citations

H-Index

Page 1

	Year	Citations
Once-Weekly Semaglutide in Adults with Overweight or Obesity John Wilding, Rachel L. Batterham, Salvatore Calanna, New England Journal of Medicine	2021	3.9K
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 Makoto Kinoshita, Koutaro Yokote, Hidenori Arai, Journal of Atherosclerosis and Thrombosis	2018	791
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The <scp>STEP</scp> 1 trial extension John Wilding, Rachel L. Batterham, Melanie J. Davies, Diabetes Obesity and Metabolism	2022	766
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species Sawako Suzuki, Tomoaki Tanaka, Masha V. Poyurovsky, Proceedings of the National Academy of Sciences Lipid PeroxidationCell DeathMolecular BiologyPhosphate-activated GlutaminaseReactive Oxygen Species	2010	669
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk Aruna D. Pradhan, Robert J. Glynn, Jean‐Charles Fruchart, New England Journal of Medicine	2022	638
Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^\|^mdash;2012 Version Tamio Teramoto, Junichi Sasaki, Shun Ishibashi, Journal of Atherosclerosis and Thrombosis HypertensionVascular DiseaseJapan Atherosclerosis SocietyCerebrovascular DiseaseCoronary Artery Disease	2013	463
Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases. Seijiro Mori, Lars Rönnstrand, Koutaro Yokote, The EMBO Journal Signal TransductionMolecular PhysiologySignaling PathwayG Protein-coupled ReceptorNatural Sciences	1993	354
Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3' kinase. Stefan Wennström, Agneta Siegbahn, Koutaro Yokote, PubMed	1994	305
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki, The Lancet Diabetes & Endocrinology Non-pharmacological InterventionDiabetes ManagementCardiovascular DiseaseHealth PolicyMedicine	2017	300
NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome Evandro Fei Fang, Yujun Hou, Sofie Lautrup, Nature Communications	2019	260

Page 1